Stock Events

Stock Events

Rakovina Therapeutics 

$0.4100
12
+$0.00+0% Friday 00:00

Statistics

Day High
0.3878
Day Low
0.3623
52W High
100
52W Low
0.289
Volume
5,000
Avg. Volume
9,730
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27NovExpected
Q1 2025
Q2 2025
Q3 2025
-0.14
-0.14
-0.13
-0.13
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2018
2019
2021
2022
2023
2024
0Revenue
-2.94MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. develops oncology drugs, directly competing in cancer treatment advancements.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb is involved in developing cancer therapies, overlapping with Rakovina's focus areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. has a significant portfolio in oncology, competing in the cancer treatment market.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company develops therapies for various cancers, directly competing with Rakovina's cancer focus.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC has a strong presence in the oncology sector, making it a direct competitor.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. focuses on oncology among other areas, competing in the cancer drug market.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. develops and markets oncology drugs, competing in the same therapeutic areas as Rakovina.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, Inc. is known for its cancer biologics, competing in oncology.
Novartis
NVS
Mkt Cap292.35B
Novartis AG has extensive research and development in oncology, aligning as a competitor in cancer treatment.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the development of oncology treatments, competing in the pharmaceutical and biotech sector for cancer therapies.

About

RAKOVINA THERAPEUTICS INC
Show more...
CEO
Dr. Mads Daugaard Ph.D.
Country
Canada

Listings

MU
DE
7JO0.MU
STU
DE
7JO0.STU
F
DE
7JO0.F
OTC Link
US
RKVTF

0 Comments

Share your thoughts

FAQ

What is Rakovina Therapeutics stock price today?▼
The current price of RKVTD is $0.41 USD — it has increased by +0% in the past 24 hours. Watch Rakovina Therapeutics stock price performance more closely on the chart.
What is Rakovina Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Rakovina Therapeutics stocks are traded under the ticker RKVTD.
What is Rakovina Therapeutics revenue for the last year?▼
Rakovina Therapeutics revenue for the last year amounts to 0 USD.
What is Rakovina Therapeutics net income for the last year?▼
RKVTD net income for the last year is -2.94M USD.
In which sector is Rakovina Therapeutics located?▼
Rakovina Therapeutics operates in the Other sector.
When did Rakovina Therapeutics complete a stock split?▼
Rakovina Therapeutics has not had any recent stock splits.
Where is Rakovina Therapeutics headquartered?▼
Rakovina Therapeutics is headquartered in Vancouver, Canada.